OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HALO$74.0057

Haloni Jane Tbk PT

Medical Equipment, Supplies & DistributionVerified

The company maintains a strong liquidity position, with a current ratio of 3.88 and cash and equivalents of IDR 29,962,043,500, indicating a solid ability to meet short-term obligations. The price-to-book ratio of 2.05 and a price-to-tangible-book ratio of 2.05 suggest the market values the company at a moderate premium to its book value. The company's return on equity of 5.02% and return on assets of 3.6% are below the typical thresholds for high-performing firms in the medical equipment and supplies industry. Profitability metrics show a gross profit of IDR 36,257,326,210 and an operating income of IDR 15,255,919,790, translating to a gross margin of 16.67% and an operating margin of 6.99%. These figures are in line with the industry's median profitability, but the company's net income of IDR 10,745,410,630 indicates a net margin of 4.94%, which is slightly below the industry average. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt. The company's revenue is concentrated in the production and export of latex gloves, with no disclosed segmental breakdown. Geographically, the company serves both local and international markets, but the input data does not provide a detailed geographic revenue distribution. The company's primary revenue source is its disposable gloves, which are sold under the Shamrock brand to a range of industries. The company's revenue growth trajectory is not explicitly provided in the input data, but the current financial snapshot indicates a stable revenue of IDR 217,498,775,850. The outlook for the current fiscal year and the next fiscal year is not specified, but the company's free cash flow of IDR 14,871,132,400 and capital expenditure of -IDR 6,517,359,210 suggest a focus on maintaining operational efficiency and reinvesting in the business. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's capital structure is free of long-term debt, and the absence of dilution risk suggests a stable equity base. The company's conservative financial position and lack of dilution risk contribute to a favorable risk profile. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's latest financial snapshot does not include any recent events or transcripts that would suggest a material change in its business strategy or financial outlook. The company's operations remain focused on the production and export of latex gloves, with no disclosed new product launches or strategic shifts.

30-day price · HALO+13.00 (+19.4%)
Low$64.00High$104.00Close$80.00As of13 May, 00:00 UTC
Profile
CompanyHaloni Jane Tbk PT
TickerHALO.JK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. PT Haloni Jane Tbk is an Indonesia-based manufacturer of disposable gloves, supplying products to medical, dental, laboratory, beauty, food processing, and industrial markets.

Classification. PT Haloni Jane Tbk is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.

The company maintains a strong liquidity position, with a current ratio of 3.88 and cash and equivalents of IDR 29,962,043,500, indicating a solid ability to meet short-term obligations. The price-to-book ratio of 2.05 and a price-to-tangible-book ratio of 2.05 suggest the market values the company at a moderate premium to its book value. The company's return on equity of 5.02% and return on assets of 3.6% are below the typical thresholds for high-performing firms in the medical equipment and supplies industry. Profitability metrics show a gross profit of IDR 36,257,326,210 and an operating income of IDR 15,255,919,790, translating to a gross margin of 16.67% and an operating margin of 6.99%. These figures are in line with the industry's median profitability, but the company's net income of IDR 10,745,410,630 indicates a net margin of 4.94%, which is slightly below the industry average. The company's debt-to-equity ratio is 0.0, reflecting a conservative capital structure with no long-term debt. The company's revenue is concentrated in the production and export of latex gloves, with no disclosed segmental breakdown. Geographically, the company serves both local and international markets, but the input data does not provide a detailed geographic revenue distribution. The company's primary revenue source is its disposable gloves, which are sold under the Shamrock brand to a range of industries. The company's revenue growth trajectory is not explicitly provided in the input data, but the current financial snapshot indicates a stable revenue of IDR 217,498,775,850. The outlook for the current fiscal year and the next fiscal year is not specified, but the company's free cash flow of IDR 14,871,132,400 and capital expenditure of -IDR 6,517,359,210 suggest a focus on maintaining operational efficiency and reinvesting in the business. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's capital structure is free of long-term debt, and the absence of dilution risk suggests a stable equity base. The company's conservative financial position and lack of dilution risk contribute to a favorable risk profile. Recent events and filings do not indicate any significant changes in the company's operations or financial position. The company's latest financial snapshot does not include any recent events or transcripts that would suggest a material change in its business strategy or financial outlook. The company's operations remain focused on the production and export of latex gloves, with no disclosed new product launches or strategic shifts.
Key takeaways
  • The company maintains a strong liquidity position with a current ratio of 3.88 and substantial cash reserves.
  • Profitability metrics are in line with industry medians, but the net margin is slightly below the typical threshold for high-performing firms.
  • The company's capital structure is conservative, with no long-term debt and a debt-to-equity ratio of 0.0.
  • The company's revenue is concentrated in the production and export of latex gloves, with no detailed segmental breakdown provided.
  • The company's risk profile is favorable, with low liquidity and dilution risks and no immediate filing-based flags detected.
  • The company's recent financial snapshot does not indicate any significant changes in operations or financial position.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$217.50B
Gross profit$36.26B
Operating income$15.26B
Net income$10.75B
R&D
SG&A
D&A
SBC
Operating cash flow-$4.77B
CapEx-$6.52B
Free cash flow$14.87B
Total assets$298.43B
Total liabilities$84.53B
Total equity$213.90B
Cash & equivalents$29.96B
Long-term debt$303.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$74.00
Market cap$438.45B
Enterprise value$408.80B
P/E40.8
Reported non-GAAP P/E
EV/Revenue1.9
EV/Op income26.8
EV/OCF
P/B2.0
P/Tangible book2.0
Tangible book$213.90B
Net cash$29.66B
Current ratio3.9
Debt/Equity0.0
ROA3.6%
ROE5.0%
Cash conversion-44.0%
CapEx/Revenue-3.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
MetricHALOActivity
Op margin7.0%13.3% medp25 5.9% · p75 13.5%below median
Net margin4.9%8.6% medp25 2.7% · p75 12.7%below median
Gross margin16.7%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-3.0%3.0% medp25 2.7% · p75 4.5%bottom quartile
Debt / equity0.0%69.3% medp25 63.4% · p75 74.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 14:09 UTC#212b83ea
Market quoteclose IDR 74.00 · shares 5.93B diluted
no public URL
2026-05-03 19:16 UTC#2dd08a95
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 19:18 UTCJob: 4ee693fe